Cuatrecasas advised Invivo Capital, Advent Biotechnology and Takeda Ventures on the round of financing in Integra Therapeutics. At closure of the transaction, the spin-off of Universitat...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here